TwitterLinkedInFacebook Instagram
United StatesLanguage Flag

Investors

Investors

OraSure Technologies, Inc. transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample collection solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Our portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers.

Stock Chart

Minimum 15 minutes delayed. Source:

Recent News
11/06/24

Q3 GAAP EPS of $(0.06) ; Q3 Non-GAAP EPS of $(0.01) OraQuick® HCV Self-test receives initial orders following receipt of WHO pre-qualification status Expanding Sample Management applications into blood proteomics Exiting Risk Assessment testing business to focus on markets with attractive growth

© OraSure Technologies., 2024